181 related articles for article (PubMed ID: 7593814)
1. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining for CD31 and CD34 in Kaposi sarcoma.
Russell Jones R; Orchard G; Zelger B; Wilson Jones E
J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622
[TBL] [Abstract][Full Text] [Related]
3. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
5. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
Poblet E; Gonzalez-Palacios F; Jimenez FJ
Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
[TBL] [Abstract][Full Text] [Related]
6. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
Pammer J; Plettenberg A; Weninger W; Diller B; Mildner M; Uthman A; Issing W; Stürzl M; Tschachler E
Am J Pathol; 1996 May; 148(5):1387-96. PubMed ID: 8623911
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of sinusoids in hepatoblastoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelium-associated antigens, including CD34.
Ruck P; Xiao JC; Kaiserling E
Histopathology; 1995 May; 26(5):451-5. PubMed ID: 7544763
[TBL] [Abstract][Full Text] [Related]
8. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases.
Ohsawa M; Naka N; Tomita Y; Kawamori D; Kanno H; Aozasa K
Cancer; 1995 Jun; 75(12):2867-74. PubMed ID: 7773935
[TBL] [Abstract][Full Text] [Related]
9. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
12. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1.
Huang YQ; Friedman-Kien AE; Li JJ; Nickoloff BJ
Arch Dermatol; 1993 Oct; 129(10):1291-6. PubMed ID: 7692824
[TBL] [Abstract][Full Text] [Related]
13. [Tufted hemangioma. Clinicopathologic and immunohistologic analysis of 5 cases of a distinct entity within the spectrum of capillary hemangioma].
Mentzel T; Wollina U; Castelli E; Kutzner H
Hautarzt; 1996 May; 47(5):369-75. PubMed ID: 8707583
[TBL] [Abstract][Full Text] [Related]
14. The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.
Schmidt D; von Hochstetter AR
Pathol Res Pract; 1995 Jun; 191(5):410-4. PubMed ID: 7479359
[TBL] [Abstract][Full Text] [Related]
15. Retiform haemangioendothelioma.
Fukunaga M; Endo Y; Masui F; Yoshikawa T; Ishikawa E; Ushigome S
Virchows Arch; 1996 Jul; 428(4-5):301-4. PubMed ID: 8764941
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle.
Zhang EG; Smith SK; Charnock-Jones DS
Reproduction; 2002 Nov; 124(5):703-11. PubMed ID: 12417009
[TBL] [Abstract][Full Text] [Related]
17. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma.
Nickoloff BJ
Arch Dermatol; 1993 Feb; 129(2):250-1. PubMed ID: 8434991
[No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of ERG, Fli-1, CD34, CD31 and FⅧRAg expression in hepatic malignant vascular tumors].
Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
[No Abstract] [Full Text] [Related]
20. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
